COCP vs SAP
Cocrystal Pharma Inc (COCP) versus SAP (SAP) — a side-by-side from cached financials, not a winner call.
Cocrystal Pharma Inc (COCP) is a biotechnology company listed on US.
SAP (SAP) common stock.
Latest reported COCP revenue for 2026-06-30 was $105.0K. Net income was -$3.2M. Revenue was down 53.3% from 2026-03-31 to 2026-06-30. COCP currently screens at market cap $13.3M.
SAP does not have a complete income-statement cache yet.
COCP currently screens at market cap $13.3M. SAP currently screens at market cap $0.
Not investment advice. Open the COCP and SAP stock pages for the full models.
Not investment advice.